Victoria H Coleman-Cowger1, Gillian L Schauer2, Erica N Peters3. 1. Battelle Public Health Center for Tobacco Research, Baltimore, MD, United States. Electronic address: colemancowger@battelle.org. 2. Health Services Department, School of Public Health, University of Washington, Seattle, WA, United States. 3. Battelle Public Health Center for Tobacco Research, Baltimore, MD, United States.
Abstract
BACKGROUND: Marijuana and tobacco are the most commonly used illicit and licit drugs during pregnancy. This study aimed to examine a nationally representative sample of US pregnant women and to: (1) determine the prevalence of past month marijuana and tobacco co-use, (2) identify characteristics that distinguish marijuana and tobacco co-users from users of marijuana only, tobacco only, or neither, and (3) compare characteristics that differ between pregnant and non-pregnant co-users of marijuana and tobacco. METHODS: Data were obtained from 497,218 US women (8721 pregnant) ages 12-49 who participated in the 2005-2014 National Survey on Drug Use and Health. Prevalence and demographic and substance use characteristics were compared across groups using weighted estimates and chi-squared tests. Multinomial logistic regression identified demographic and substance use correlates of co-use. RESULTS: Co-use among pregnant and non-pregnant women was significantly more prevalent than marijuana-only use but was less common than tobacco-only use. In unadjusted frequencies, pregnant co-users significantly differed from non-pregnant co-users across several domains. Among pregnant women, multivariate correlates of co-use of tobacco and marijuana vs. tobacco-only use were ages 12-17, non-Hispanic black race, Hispanic ethnicity, and past month polytobacco, any alcohol, and other drug use (all adjusted odds ratios≥2.0). CONCLUSIONS: In this first examination of the prevalence and correlates of co-use of marijuana and tobacco among a nationally representative group of pregnant women, pregnant co-users were more likely to report other high risk behaviors compared with non-pregnant co-users and users of a single substance, suggesting disparities worthy of further investigation.
BACKGROUND:Marijuana and tobacco are the most commonly used illicit and licit drugs during pregnancy. This study aimed to examine a nationally representative sample of US pregnant women and to: (1) determine the prevalence of past month marijuana and tobacco co-use, (2) identify characteristics that distinguish marijuana and tobacco co-users from users of marijuana only, tobacco only, or neither, and (3) compare characteristics that differ between pregnant and non-pregnant co-users of marijuana and tobacco. METHODS: Data were obtained from 497,218 US women (8721 pregnant) ages 12-49 who participated in the 2005-2014 National Survey on Drug Use and Health. Prevalence and demographic and substance use characteristics were compared across groups using weighted estimates and chi-squared tests. Multinomial logistic regression identified demographic and substance use correlates of co-use. RESULTS: Co-use among pregnant and non-pregnant women was significantly more prevalent than marijuana-only use but was less common than tobacco-only use. In unadjusted frequencies, pregnant co-users significantly differed from non-pregnant co-users across several domains. Among pregnant women, multivariate correlates of co-use of tobacco and marijuana vs. tobacco-only use were ages 12-17, non-Hispanic black race, Hispanic ethnicity, and past month polytobacco, any alcohol, and other drug use (all adjusted odds ratios≥2.0). CONCLUSIONS: In this first examination of the prevalence and correlates of co-use of marijuana and tobacco among a nationally representative group of pregnant women, pregnant co-users were more likely to report other high risk behaviors compared with non-pregnant co-users and users of a single substance, suggesting disparities worthy of further investigation.
Authors: Laura R Stroud; George D Papandonatos; Meaghan McCallum; Tessa Kehoe; Amy L Salisbury; Marilyn A Huestis Journal: Neurotoxicol Teratol Date: 2018-09-26 Impact factor: 3.763
Authors: Victoria H Coleman-Cowger; Wallace B Pickworth; Robert A Lordo; Erica N Peters Journal: Am J Public Health Date: 2018-06-21 Impact factor: 9.308
Authors: Suena H Massey; Daniel K Mroczek; James L Burns; Caron A C Clark; Kimberly A Espy; Lauren S Wakschlag Journal: Neurotoxicol Teratol Date: 2018-03-06 Impact factor: 3.763
Authors: Laura R Stroud; George D Papandonatos; Nancy C Jao; Chrystal Vergara-Lopez; Marilyn A Huestis; Amy L Salisbury Journal: Neurotoxicol Teratol Date: 2020-04-11 Impact factor: 3.763